On June 4, 2024, Nathan Jorgensen, Ph.D., M.B.A., notified Vor Biopharma Inc. of his resignation as Chief Financial Officer of the Company, effective as of June 21, 2024 (the Effective Date), in order to pursue a new opportunity. Dr. Jorgensen's resignation is not because of a disagreement with the Company on any matter relating to the Company's operations, policies or practices. The Company is currently conducting a search process to identify a new Chief Financial Officer.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.15 USD | 0.00% | -4.58% | -49.11% |
13/06 | Voyager Therapeutics Names Nathan Jorgensen as Finance Chief | MT |
10/06 | Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.11% | 78.5M | |
+21.03% | 46.93B | |
+37.63% | 39.08B | |
-8.14% | 38.48B | |
+29.25% | 31.01B | |
-13.75% | 26.14B | |
+10.72% | 25.88B | |
+36.29% | 12.53B | |
-6.98% | 11.36B | |
-12.60% | 10.65B |
- Stock Market
- Equities
- VOR Stock
- News Vor Biopharma Inc.
- Nathan Jorgensen Resigns as Chief Financial Officer of Vor Biopharma Inc., Effective June 21, 2024